Brigid Makes - 12 May 2025 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Role
Chief Financial Officer
Signature
/s/ Brigid Makes as Attorney-in-fact
Issuer symbol
VANI
Transactions as of
12 May 2025
Net transactions value
$0
Form type
4
Filing time
14 May 2025, 20:31:54 UTC
Previous filing
10 Jun 2024
Next filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Makes Brigid Chief Financial Officer C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA /s/ Brigid Makes as Attorney-in-fact 14 May 2025 0001375927

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VANI Common Stock Option Award $0 +75,000 $0.000000 75,000 12 May 2025 Common Stock 75,000 $1.03 Direct F1
transaction VANI RSUs Award $0 +37,500 $0.000000 37,500 12 May 2025 Common Stock 37,500 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
F3 The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.